| Literature DB >> 31319629 |
Alexandr E Urusov1, Anatoly V Zherdev1, Boris B Dzantiev2.
Abstract
Point-of-care (POC) or bedside analysis is a global trend in modern diagnostics. Progress in POC testing has largely been provided by advanced manufacturing technology for lateral flow (immunochromatographic) test strips. They are widely used to rapidly and easily control a variety of biomarkers of infectious diseases and metabolic and functional disorders, as well as in consumer protection and environmental monitoring. However, traditional lateral flow tests rely on visual assessment and qualitative conclusion, which limit the objectivity and information output of the assays. Therefore, there is a need for approaches that retain the advantages of lateral flow assays and provide reliable quantitative information about the content of a target compound in a sample mixture. This review describes the main options for detecting, processing, and interpreting immunochromatographic analysis results. The possibilities of modern portable detectors that register colored, fluorescent, magnetic, and conductive labels are discussed. Prospects for further development in this direction are also examined.Entities:
Keywords: immunoassay; immunochromatography; optical detection; portable detectors; rapid tests
Year: 2019 PMID: 31319629 PMCID: PMC6784366 DOI: 10.3390/bios9030089
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Common structure of lateral flow test strip and interaction of reactants in the course of the assay.
Figure 2General principle of the optical registration of an immunochromatographic assay. Notations 1–5 are explained in the text.
Manufacturers and models of optical detectors for registering results of immunochromatography (based on [19], with actualization and additions).
| Company | Country | Website | Detector Model | Mode of Measurements |
|---|---|---|---|---|
| Abingdon Health | United Kingdom | abingdonhealth.com | Lateral Flow Reader OEM | Colorimetry |
| Alere Toxicology | United Kingdom | aleretoxicology.co.uk | Alere™ DDS®2 Mobile Test System | Colorimetry |
| Axxin | Australia | axxin.com | AXXIN AX-2X | Colorimetry, fluorimetry |
| BD Company | United States | bd.com | BD Veritor System, BD Veritor Plus System | Colorimetry |
| Bio-AMD | United Kingdom | bioamd.com | Digital Strip Reader | Colorimetry |
| BioAssay Works | United States | bioassayworks.com | Cube-Reader | Colorimetry |
| Biohit Healthcare | Finland | biohithealthcare.com | Biohit Quick Test Reader (QTR) | Colorimetry |
| Bio-group Medical System | Italy | biogms.com | Nemesys System | Colorimetry |
| Charm Scientific | United States | charm.com | Charm EZ Lite System, Charm EZ System | Colorimetry |
| Concile | Germany | concile.de | CONCILE Ω100 | Colorimetry |
| Detekt | United States | idetekt.com | RDS-1500, RDS-2500 | Colorimetry |
| Dr. Fooke | Germany | fooke-labs.de | LFA Reader | Colorimetry |
| GenPrime | United States | genprime.com | Point-of-Care Diagnostic System | Colorimetry |
| Hamamatsu | Japan | hamamatsu.com | Immunochromato-Reader C10066 | Colorimetry |
| Immunochromato-Reader C11787 | Colorimetry, fluorimetry | |||
| Hund Wetzlar | Germany | hund.de | Lateral Flow Tester LFT 100 | Colorimetry |
| Esterline | Germany | esterline.com | cPoC Reader | Colorimetry |
| Maxwell Sensors | United States | maxwellsensors.com | FS-Scanner | Fluorimetry |
| Megalab | Greece | www.megalab.gr | Easy Reader | Colorimetry |
| Merck Millipore | Germany | merckmillipore.com | RQflex 20 | Colorimetry |
| Neogen | United States | neogen.com | AccuScan GOLD | Colorimetry |
| Optricon | Germany | optricon.de | opTrilyzer®Med, opTrilyzer®Med Plus, Cube-Reader | Colorimetry |
| opTrilyzer®Med Fluo | Colorimetry, fluorimetry | |||
| Qiagen | Germany | qiagen.com | ESEQuant LFR | Colorimetry, fluorimetry |
| Reagena | Finland | reagena.com | ReaScan | Colorimetry |
| Response Biomedical | Canada | responsebio.com | RAMP®Reader | Colorimetry, fluorimetry |
| Romer Labs | Austria | romerlabs.com | AgraVision™ | Colorimetry |
| Skannex AS | Norway | skannex.com | ScanEasy, SkanFlexi X200, SkanFlexi X500 | Colorimetry |
| Shanghai Kinbio Tech | China | kinbio.com | Kinbio DT1030n Kinbio DL2032 | Colorimetry |
| Shenzhen Highcreation Technology | China | www.hkrgr.com | Reader HR201 | Colorimetry |
| Sugentech | Korea | sugentech.com | INCLIX; INCLIX™ S900 | Colorimetry |
| Synteco | Russia | synteco.ru | Reflecom Narcology, Reflecom Multitest | Colorimetry |
| Ushio Biomedical | Japan | www.ushiomedical.com | Point Reader V | Colorimetry |
| Vedalab | France | vedalab.com | Easy Reader | Colorimetry |
| VICAM | United States | vicam.com | Vertu Lateral Flow Reader | Colorimetry |
Examples of quantitative lateral flow tests and their working ranges reached in combination with commercial detectors.
| Detector Model | Target Analytes | Range of Concentration Measured |
|---|---|---|
| Nemesys System (Bio-group Medical System) | Fecal occult blood | 30–1000 ng/mL |
| Calprotectin | 20–250 µg/g | |
| Tetanus | 0.01–0.51 IU/mL | |
| Celiac | 8–50 IU/mL | |
| CONCILE Ω100 (Concile) | Alpha-fetoprotein | 125–200 ng/mL |
| Cancer antigen 125 | 20–500 U/mL | |
| Carbohydrate antigen 15-3 | 10–400 U/mL | |
| Carbohydrate antigen 19-9 | 15–400 U/mL | |
| Carcinoembryonic antigen | 2.5–150 ng/mL | |
| Free prostate-specific antigen | 0.5–10 ng/mL | |
| Prostate-specific antigen | 0.5–25 ng/mL | |
| Urinary bladder cancer antigen | 5–300 µg/mL | |
| Human chorionic gonadotropin | 5–400 mIU/mL | |
| Luteinizing hormone | 5–200 mIU/mL | |
| Follicle-stimulating hormone | 2.5–100 mIU/mL | |
| Thyroid-stimulating hormone | 0.3–40 mIU/L | |
| Testosterone | 0.25–16 ng/mL | |
| 25-OH-vitamin D | 3–100 ng/mL | |
| C-reactive protein | 0.5–100 mg/L | |
| Neopterin | 2.5–100 nmol/L | |
| Brain natriuretic peptide | 100–3000 pg/mL | |
| Troponin I | 0.5–50 ng/mL | |
| Heart-type fatty-acid-binding protein | 2.5–100 ng/mL | |
| Phospholipase A2-IIA | 20–500 ng/mL | |
| Easy Reader (Vedalab) | Alpha-fetoprotein | 10–300 ng/mL |
| Beta-chain-specific human chorionic gonadotrophin | 5–1000 IU/L | |
| C-peptide | 0.5–40 ng/mL | |
| CA 125 (ovarian cancer antigen) | 15–750 U/mL | |
| Cancer antigen 15-3 | 5–200 IU/mL | |
| Calprotectin | 25–350 µg/g | |
| Carcinoembryonic antigen | 5–250 ng/mL | |
| Creatine kinase MB | 5–200 ng/mL | |
| Cortisol | 25–250 ng/mL | |
| C-reactive protein | 2.5–400 µg/mL | |
| High-sensitivity C-reactive protein | 0.1–400 µg/mL | |
| Cystatin C | 0.1–8 mg/L | |
| D-dimer | 250–5000 ng/mL | |
| Heart-type fatty-acid-binding protein | 2–120 ng/m | |
| Ferritin | 10–630 ng/mL | |
| Fecal occult blood (hemoglobin) | 10–499 ng/mL | |
| Follicle-stimulating hormone | 5–400 IU/L | |
| Hemoglobin total | 5–25 g/dL | |
| Glycated hemoglobin | 4%–16% | |
| Human chorionic gonadotrophin | 5–1000 IU/L | |
| High-sensitivity insulin | 2–200 µIU/mL | |
| High-sensitivity prolactin | 3–100 ng/mL | |
| High-sensitivity thyroid-stimulating hormone | 1–80 mIU/L | |
| Immunoglobulin E | 10–800 IU/mL | |
| Insulin | 5–200 µIU/mL | |
| Luteinizing hormone | 5–400 mIU/mL | |
| Microalbumin | 2.5–5000 µg/mL | |
| Myoglobin | 50–500 ng/mL | |
| Procalcitonin | 0.3–100 ng/mL | |
| Prolactin | 20–350 ng/mL | |
| Prostate-specific antigen | 1–100 ng/mL | |
| Total T3 | 0.3–6 ng/mL | |
| Total T4 | 0.6–15 µg/dL | |
| Transferrin | 4–300 ng/mL | |
| Troponin I | To 50 ng/mL | |
| Thyroid-stimulating hormone | 2–80 mIU/L | |
| Ultrasensitive thyroid-stimulating hormone | 0.2–50 mIU/L | |
| INCLIX (Sugentech) | Thyroid-stimulating hormone, vitamin D, D-dimer | No data published |
| Easy Reader (Megalab) | Alpha-fetoprotein, Cancer antigen 125, Carcinoembryonic antigen, Creatine kinase MB, C-reactive protein, high-sensitivity C-reactive protein, D-Dimer, Ferritin, Fecal occult blood, Follicle-stimulating hormone, Luteinizing hormone, IgE, Insulin, Luteinizing hormone, Microalbumin, Myoglobin, Prolactin, Prostate-specific antigen, Troponin I, Thyroid-stimulating hormone | No data published |
Examples of smartphone/mobile-phone-based quantitative lateral flow assays and their analytical parameters.
| Detecting Device and Construction | Target Analytes | Range of Concentration Measured | Reference |
|---|---|---|---|
| UC-LFS platform | Brain natriuretic peptide | 5–100 pg/mL | [ |
| Suppression of tumorigenicity 2 | 1–25 ng/mL | ||
| Dual LFIA with iPhone 5s |
| 20–107 CFU/mL | [ |
| 34–107 CFU/mL | |||
| Smartphone-app-chip (SPAC) system | Aflatoxins | 0.5–250 ppb | [ |
| REDCap tests with iPhone |
| 12.5–500 parasites/μL | [ |
| Smartphone Diagnostics Unit (SDU) | C-reactive protein | 0.1 (amplified LFIA)/1 (nonamplified LFIA) to 100 ng/mL (for both compounds) | [ |
| Cortisol | |||
| Smartphone’s ambient-light-sensor-based reader (SPALS-reader) | Cadmium ion | 0.16–50 ng/mL | [ |
| Clenbuterol | 0.046–1 ng/mL | ||
| Porcine epidemic diarrhea virus | 0.055–20 μg/mL | ||
| iPhone-5s-based solution | Digoxigenin | 16.9–100 nM | [ |
| iPhone-based solution | Cocaine | 0.01–1.0 μg/mL | [ |
Figure 3Working window in the Total Lab Quant software and its use for the quantitative assessment of immunochromatography results. (1) Image of test strips array, (2) distribution of staining intensity along the analyzed test strip, (3) identification data of the bonding zone and assessment of its staining intensity, and (4) zoomed-in image of the analyzed test strip.
Figure 4Comparison of optical and magnetic detection of immunochromatography results. (1) Contacting membrane, (2) plastic base layer, (3) colloidal gold or latex particles, and (4) magnetic particles. The membrane’s zones where the bonded labels are registered are highlighted in red.
Magnetic registering detectors for quantitative lateral flow assays.
| Company | Country | Website | Detector Model | Open System |
|---|---|---|---|---|
| Magna BioSciences | United States | magnabiosciences.com | MICT® Bench-Top System | + |
| Magnasense Technologies | Finland | magnasense.com | Magnasense’s Magnetometric Reader | + |
| VWR International | United States | vwr.com | FoodChek™’s MICT System | − |
Figure 5Limits of detection of the competing immunoassay (from [55], with additions and amendments). Visual detection can determine whether or not there is staining; detection limit corresponds to point A dividing these options. Instrumental detection can register staining intensity that can be compared to the values stored in the device’s memory. Detection limit corresponds to point B—the minimum concentration that causes a reliable lowering of staining intensity compared to the negative (zero) sample.